USPTO serial 98978823
SERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- FAIRBANKS, RONALD L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Salt Lake City, UT, US
Salt Lake City, UT, US
Salt Lake City, UT, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura M. Franco
Laura M. Franco Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.44 Montgomery Street, 36th FloorSan Francisco, CA 94104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical test kits for home use for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; preparations for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; medical test kits for use in a doctor's office for testing for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease | ACTIVE | Jul 31, 2025 |
| 041 | Educational services, namely, providing a website featuring non-downloadable webcasts, photographs, and audio and video recordings featuring stories and articles in the field of current events relating to menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy-related issues, conditions, features, complications, women's body measurements, gynecological, sexual, and emotional health information, and related women's health issues; providing online non-downloadable journals, non-downloadable articles and blogs on topics related to women's health and pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, conditions, features and complications | ACTIVE | Nov 18, 2024 |
| 044 | Medical testing services for pregnancy, pregnancy planning, pregnancy tracking and management, and pregnancy-related issues, features, conditions, or complications; medical diagnostic testing services to detect pregnancy and for pregnancy planning, pregnancy tracking and management, and pregnancy-related health issues, features, conditions, or complications, namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; providing a website featuring health information about women's health and pregnancy and pregnancy planning, pregnancy tracking and management, pregnancy-related health features, issues, conditions or complications namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; providing health information related to pregnancy, pregnancy tracking and management, and pregnancy-related health features, issues, conditions or complications namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease via e-mail and online; providing current news, information and commentary in the fields of menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy- related health features, issues, conditions or complications, namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease, women's body measurements for medical purposes, gynecological, sexual, and emotional health information, and related women's health issues; providing an internet news website portal featuring links to news stories and articles in the field of current events relating to menstrual cycles, ovulation, fertility, pregnancy, pregnancy planning, pregnancy tracking and management, pregnancy-related health issues, conditions, features or complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease, women's body measurements, gynecological, sexual, and emotional health information, and related women's health issues; Medical laboratory analysis services relating to pregnancy testing, pregnancy planning, pregnancy tracking and management, and pregnancy-related features, issues, conditions or complications namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Providing medical diagnostic testing services to detect pregnancy related issues, features, conditions, and complications, including risk of preterm birth, pre-term labor, imminent preterm birth, risk of preeclampsia, imminent preeclampsia, risk of gestational diabetes, gestation diabetes, risk of gestation hypertension, gestational hypertension, risk of fetal growth restriction, fetal growth restriction, risk of post-partum depression, and post-partum depression, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Providing information on pregnancy and pregnancy related health topics, namely, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; menstrual disorders, infertility, endometriosis, uterine fibroids, polycystic ovary syndrome, sexually transmitted infections, and menopause; Medical testing services; Medical testing services to predict risk of pre-term birth, pre-term labor, preeclampsia, gestational diabetes, gestation hypertension, fetal growth restriction, and post-partum depression, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease. | ACTIVE | Nov 18, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sera Prognostics, Inc.
- Other trademarks owned by Sera Prognostics, Inc.
- Other trademarks owned by Sera Prognostics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named SERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 27, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 27, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 30, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 30, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jul 1, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 10, 2026 | IUAF | USE AMENDMENT FILED | — |
| Apr 10, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 10, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Apr 10, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 20, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 20, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 20, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 26, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 19, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 18, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2024 | NWAP | NEW APPLICATION ENTERED | — |